πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 19 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12427173

Use of bacteria, bacterial products, and other immunoregulatory entities in combination wi

Biomed Valley Discoveries, Inc. Β· Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12076324

Cancer treatments using combinations of CDK and ERK inhibitors

Biomed Valley Discoveries, Inc. Β· Granted Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11679112

Cancer treatments using combinations of CDK and ERK inhibitors

Biomed Valley Discoveries, Inc. Β· Granted Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11439669

C. novyi for the treatment of solid tumors in humans

Biomed Valley Discoveries, Inc. Β· Granted Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11246859

Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

Biomed Valley Discoveries, Inc. Β· Granted Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11135225

Cancer treatments using combinations of CDK and ERK inhibitors

Biomed Valley Discoveries, Inc. Β· Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11033537

LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

Biomed Valley Discoveries, Inc. Β· Granted Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11013743

Cancer treatments using combinations of CDK and ERK inhibitors

Biomed Valley Discoveries, Inc. Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11007183

Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors

Biomed Valley Discoveries, Inc. Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11007184

Cancer treatments using combinations of type 2 MEK and ERK inhibitors

Biomed Valley Discoveries, Inc. Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10881646

Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

Biomed Valley Discoveries, Inc. Β· Granted Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10716782

LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

Biomed Valley Discoveries, Inc. Β· Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10668055

Cancer treatment using combinations of ERK and RAF inhibitors

Biomed Valley Discoveries, Inc. Β· Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10617723

C. novyi for the treatment of solid tumors in humans

Biomed Valley Discoveries, Inc. Β· Granted Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10485796

LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

Biomed Valley Discoveries, Inc. Β· Granted Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9951041

Crystalline C21H22Cl2N4O2 malonate

Biomed Valley Discoveries, Inc. Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9861621

LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

Biomed Valley Discoveries, Inc. Β· Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9757424

Compositions and methods of treating gliomas

Biomed Valley Discoveries, Inc. Β· Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9670177

Crystalline C21H22Cl2N4O2 malonate

Biomed Valley Discoveries, Inc. Β· Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted